A Loubatières

863 total citations
63 papers, 621 citations indexed

About

A Loubatières is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, A Loubatières has authored 63 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in A Loubatières's work include Diet, Metabolism, and Disease (13 papers), Pancreatic function and diabetes (9 papers) and Diabetes Management and Research (8 papers). A Loubatières is often cited by papers focused on Diet, Metabolism, and Disease (13 papers), Pancreatic function and diabetes (9 papers) and Diabetes Management and Research (8 papers). A Loubatières collaborates with scholars based in France and United States. A Loubatières's co-authors include M. M. Mariani, Gérard Ribes, R Alric, J Chapal, Marie-Madeleine Loubatières-Mariani, G Valette, A Sassine, Julian Taylor, G Valette and M. Manteghetti and has published in prestigious journals such as Diabetes, Annals of the New York Academy of Sciences and Diabetologia.

In The Last Decade

A Loubatières

42 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Loubatières France 12 356 308 199 90 73 63 621
M. M. Mariani France 7 210 0.6× 233 0.8× 134 0.7× 56 0.6× 75 1.0× 8 405
Ae. Lambert Belgium 12 311 0.9× 292 0.9× 173 0.9× 145 1.6× 73 1.0× 35 599
J. Marchand Belgium 14 322 0.9× 404 1.3× 207 1.0× 124 1.4× 98 1.3× 32 566
John Myhre Denmark 6 502 1.4× 287 0.9× 177 0.9× 27 0.3× 165 2.3× 7 737
Bernd J. Zünkler Germany 14 95 0.3× 230 0.7× 359 1.8× 40 0.4× 56 0.8× 22 680
M. Komjati Austria 11 253 0.7× 221 0.7× 159 0.8× 78 0.9× 91 1.2× 25 471
Gabriella Andraghetti Italy 16 222 0.6× 391 1.3× 211 1.1× 15 0.2× 327 4.5× 29 787
Jean‐Claude Daubresse Belgium 10 195 0.5× 142 0.5× 101 0.5× 121 1.3× 63 0.9× 18 411
Mark Waring Germany 8 98 0.3× 90 0.3× 113 0.6× 148 1.6× 19 0.3× 9 472
Carolyn Mickel United States 4 793 2.2× 322 1.0× 373 1.9× 34 0.4× 32 0.4× 5 931

Countries citing papers authored by A Loubatières

Since Specialization
Citations

This map shows the geographic impact of A Loubatières's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Loubatières with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Loubatières more than expected).

Fields of papers citing papers by A Loubatières

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Loubatières. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Loubatières. The network helps show where A Loubatières may publish in the future.

Co-authorship network of co-authors of A Loubatières

This figure shows the co-authorship network connecting the top 25 collaborators of A Loubatières. A scholar is included among the top collaborators of A Loubatières based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Loubatières. A Loubatières is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loubatières, A, et al.. (2003). [Effects of p-aminobenzene-sulfamido-isopropylthiodiazol on glycemia, on the structure of the islands of Langerhans and on the metabolism of normal or diabetic animals].. PubMed. 149(15-18). 1642–6.
2.
Loubatières, A, et al.. (2003). [The pituitary gland and mechanism of action of N'-(5-isopropyl-1, 3, 4-thiodiazol-2-yl) sulfanilamide].. PubMed. 48(3). 620–4.
3.
Loubatières, A, et al.. (2003). [Effects of serotonin on heart].. PubMed. 149(15-18). 1634–6.
4.
Loubatières, A, et al.. (1975). [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].. PubMed. 1. 13–21. 4 indexed citations
5.
Loubatières, A, Marie-Madeleine Loubatières-Mariani, R Alric, & Gérard Ribes. (1974). Tolbutamide and Glueagon Secretion. Diabetologia. 10(4). 271–276. 13 indexed citations
6.
Loubatières, A, et al.. (1971). Démonstration expérimentale de l'action stimulante des biguanides (peenformine, metrormine) sur l'insulinosécrétion.. Comptes rendus hebdomadaires des séances de l Académie des sciences. 272(2). 1 indexed citations
7.
Loubatières, A. (1969). [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].. PubMed. 6 Suppl 1. 216–55. 11 indexed citations
8.
Loubatières, A, et al.. (1969). [Synergism between glucose and tolbutamide in the physiopathologic limits of blood sugar levels].. PubMed. 269(15). 1460–3. 3 indexed citations
9.
Loubatières, A, M. M. Mariani, & R Alric. (1968). THE ACTION OF DIAZOXIDE ON INSULIN SECRETION, MEDULLO‐ADRENAL SECRETION, AND THE LIBERATION OF CATECHOLAMINES. Annals of the New York Academy of Sciences. 150(2). 226–241. 26 indexed citations
10.
Loubatières, A, et al.. (1966). Démonstration de l'action inhibitrice directe du diazoxide sur la sécrétion d'insuline par le pancréas.. Comptes rendus hebdomadaires des séances de l Académie des sciences. 262(19). 2 indexed citations
11.
Loubatières, A, et al.. (1966). Mécanisme d'action d'un sulfonamide hyperglycémiant: le Diazoxide.. Annales d Endocrinologie. 27(6). 1 indexed citations
12.
Loubatières, A, et al.. (1964). [CHARACTERISTICS OF DIABETES MELLITUS INDUCED IN DOGS BY ADRENALINE PERFUSION INTO THE BLOOD IRRIGATING THE PANCREAS].. PubMed. 259. 441–3. 1 indexed citations
13.
Loubatières, A. (1959). GENERAL PHARMACODYNAMICS OF THE HYPOGLYCEMIC ARYLSULFONAMIDES. Annals of the New York Academy of Sciences. 74(3). 413–418. 10 indexed citations
14.
Loubatières, A. (1958). [Hypoglycemic & antidiabetic arylsulfonamides. I. Experimental study of their mechanism of action].. PubMed. 66(51). 1175–8. 1 indexed citations
15.
Loubatières, A. (1957). THE MECHANISM OF ACTION OF THE HYPOGLYCEMIC SULFONAMIDES: A CONCEPT BASED ON INVESTIGATIONS IN ANIMALS AND IN HUMAN BEINGS. Annals of the New York Academy of Sciences. 71(1). 192–206. 23 indexed citations
16.
Loubatières, A. (1956). THE USE OF CERTAIN SULFONAMIDES IN THE TREATMENT OF EXPERIMENTAL DIABETES MELLITUS. Annals of the New York Academy of Sciences. 67(7). 187–206. 5 indexed citations
17.
Loubatières, A. (1955). [Sulfamide substances in the treatment of sugar diabetes: personal resaerch (1946-1955); experimental confirmation of recent developments].. PubMed. 63(83). 1728–30. 2 indexed citations
18.
Loubatières, A, et al.. (1955). [Analysis of the tonodiastolic action of digitalics on papillary muscle fatigued by simple stretching; effects of hexamethonium and 2-4 dinitrophenol].. PubMed. 47(1). 223–7. 1 indexed citations
19.
Loubatières, A. (1951). [Cardiotonic properties of an alphatic amino alcohol, 6-amino-2-methyl-2-heptanol].. PubMed. 85(3-4). 333–56. 4 indexed citations
20.
Loubatières, A. (1951). [Pharmacodynamics of the principles of digitalis; a study using the papillary muscle of the mammalian heart, with special reference to that of man].. PubMed. 85(1-2). 49–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026